Coronary Artery Disease

SELECT: Semaglutide Reduces Hospital Admissions

Radcliffe CVRM

Tirzepatide Noninferior to Dulaglutide for CV Events

Radcliffe CVRM

Olpasiran's ApoB Reduction Explained by Lp(a) Clearance

Radcliffe Cardiology

LDL-C, Lp(a) & Hs-CRP Predict CV Events Synergistically

Radcliffe Cardiology

Metabolic Surgery Superior to GLP-1 RAs for Long-Term Outcomes in Patients with Diabetes and Obesity

Radcliffe CVRM

ESC Take-homes: Revolutionising Thrombosis Treatment in ACS, SSP and AF

Carolyn Lam, Jeffrey Weitz

Watch time: 10m 29s

Davide Capodanno, Sneha Shah Jain

Watch time: 19m 30s (6 videos)
ESC 25: LipoaScreen: Cascade Screening for LP(a)

Jonas Brinck

Watch time: 3m 23s

Broadcast

Anticoagulation

Electrophysiology & Arrhythmia
Your Questions Answered: Revolutionising Thrombosis Treatment

Carolyn Lam, Jeffrey Weitz, Sneha Shah Jain, et al

Watch time: 31m 49s

Joost Daemen, Nicolas M Van Mieghem

Watch time: 5h 48m 39s (30 videos)
Total ApoB and Lp(a) Count Deemed Superior for CAD Risk Assessment

Radcliffe CVRM

Radcliffe CVRM

Joost Daemen, Nicolas M Van Mieghem

Watch time: 5h 48m 39s (30 videos)
ESC Take-homes: Revolutionising Thrombosis Treatment in ACS, SSP and AF

Carolyn Lam, Jeffrey Weitz

Watch time: 10m 29s

Davide Capodanno, Sneha Shah Jain

Watch time: 19m 30s (6 videos)

Nicholas Nguyen, Katherine C Michelis

Read time: 20m 28s
ESC 25: LipoaScreen: Cascade Screening for LP(a)

Jonas Brinck

Watch time: 3m 23s
AHA 23: Preventive Cardiology in 2023

Michael Honigberg

Watch time: 7m 3s
LDL-C, Lp(a) & Hs-CRP Predict CV Events Synergistically

Radcliffe Cardiology

Olpasiran's ApoB Reduction Explained by Lp(a) Clearance

Radcliffe Cardiology

SELECT: Semaglutide Reduces Hospital Admissions

Radcliffe CVRM

Ru Ying Fong, Annie Lee, Fei Gao, et al

Read time: 18m
Tirzepatide Noninferior to Dulaglutide for CV Events

Radcliffe CVRM

ACC 2025: Lifetime Benefit by Control of Modifiable Risk Factors

Christina Magnussen

Watch time: 2m 46s

Media

Davide Capodanno, Sneha Shah Jain

Watch time: 19m 30s (6 videos)

Broadcast

Anticoagulation

Electrophysiology & Arrhythmia
Your Questions Answered: Revolutionising Thrombosis Treatment

Carolyn Lam, Jeffrey Weitz, Sneha Shah Jain, et al

Watch time: 31m 49s

Joost Daemen, Nicolas M Van Mieghem

Watch time: 5h 48m 39s (30 videos)
ESC 25: LipoaScreen: Cascade Screening for LP(a)

Jonas Brinck

Watch time: 3m 23s
ESC Take-homes: Revolutionising Thrombosis Treatment in ACS, SSP and AF

Carolyn Lam, Jeffrey Weitz

Watch time: 10m 29s
ACC 2025: Lifetime Benefit by Control of Modifiable Risk Factors

Christina Magnussen

Watch time: 2m 46s
AHA 23: Preventive Cardiology in 2023

Michael Honigberg

Watch time: 7m 3s

Articles

Lifestyle Modification after PCI

Nicholas Nguyen

,

Katherine C Michelis

,

Published:

09 January 2025

Citation:

US Cardiology Review 2025;19:e01.

DOI:

https://doi.org/10.15420/usc.2024.34
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 1404
  • Downloads: Downloads 132
  • Citations: 3
  • Read time: 20m 28s

Cardiometabolic Risk Factors and COVID-19 in the Asia-Pacific Region

Ru Ying Fong

,

Annie Lee

,

Fei Gao

,

Jonathan Jiunn Liang Yap

,

Khung Keong Yeo

,

Published:

23 June 2023

Citation:

Journal of Asian Pacific Society of Cardiology 2023;2:e22.

DOI:

https://doi.org/10.15420/japsc.2022.27
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 336
  • Downloads: Downloads 18
  • Citations: 2
  • Read time: 18m